A Novel Tongue Squamous Cell Carcinoma Cell Line Escapes from Immune Recognition due to Genetic Alterations in <i>HLA</i> Class I Complex
Immune checkpoint inhibitors (ICI) have made progress in the field of anticancer treatment, but a certain number of PD-L1 negative OSCC patients still have limited benefits from ICI immuno-therapy because of primary immune evasion due to immunodeficiency. However, in existing human OSCC cell lines,...
Main Authors: | Xiaofeng Zheng, Yanan Sun, Yiwei Li, Jiyuan Ma, Yinan Lv, Yaying Hu, Yi Zhou, Jiali Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/12/1/35 |
Similar Items
-
Oral Potentially Malignant Disorders and <i>Candida</i> in Oral Tongue Squamous Cell Carcinoma Patients
by: Orvokki Saraneva, et al.
Published: (2023-07-01) -
Tumor Escape Phenotype in Bladder Cancer Is Associated with Loss of HLA Class I Expression, T-Cell Exclusion and Stromal Changes
by: Hernani Gil-Julio, et al.
Published: (2021-07-01) -
Tumor Microenvironment, HLA Class I and APM Expression in HPV-Negative Oral Squamous Cell Carcinoma
by: Claudia Wickenhauser, et al.
Published: (2021-02-01) -
HLA-B and HLA-C Differ in Their Nanoscale Organization at Cell Surfaces
by: Philippa R. Kennedy, et al.
Published: (2019-01-01) -
Squamous cell carcinoma of the tongue in patients older than 45 years
by: Constantino Ledesma-Montes, et al.
Published: (2018-12-01)